Non-Invasive, Non-pharmacologic, Computer Interface Approach to Modulate Electroencephalogram (EEG) Potentials, Alertness and Sleep With Acoustic Stimulation
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Sleep
- Sponsor
- Elemind Technologies, Inc.
- Enrollment
- 200
- Locations
- 1
- Primary Endpoint
- Change in Sleep Onset Latency (SOL) from Sham Block Compared to Stimulation Block
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
This study seeks to test whether auditory stimulation delivered at specific phases of the alpha oscillation (as measured by electroencephalogram) can accelerate sleep onset.
Detailed Description
In healthy sleepers, cortical alpha oscillations are present during the transition from wakefulness to sleep, and dissipate at sleep onset. For individuals with insomnia, alpha power is elevated during the wake-sleep transition and can persist throughout the night. This study tests whether a wearable device that delivers auditory stimulation phase-locked to alpha oscillations can accelerate sleep onset in healthy adults who report difficulties falling and staying asleep. The device is a prototype of the Elemind Neuromodulation system (ENMod). The ENMod is a wireless headband that measures brain signals, computes the phase of neural oscillations in specific frequency bands, and delivers audible pink noise pulses at specific times relative to the instantaneous phase of neural oscillations. In this study, we ask participants to wear the ENMod headband at home while going to sleep. The device is programmed to record EEG activity and, during the transition from wakefulness to sleep, deliver phase-locked sounds that are intended to interact with the participants neural activity and accelerate sleep onset.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Able to provide informed consent after reading and answering questions in written English
- •Self-report that it takes 30 minutes on average or more to fall asleep
- •Subthreshold to Moderately severe Clinical insomnia symptoms (ISI \< 21)
- •Subthreshold to Moderately severe Clinical insomnia (PSQI \> 6)
- •Minimal risk for severe Generalized Anxiety Disorder (GAD-7 \< 15)
- •Minimal risk for severe Generalized Anxiety Disorder (GAD-7 \< 15)
- •Individuals that are not actively being treated for anxiety, insomnia, ADHD or other psychological disorders with medications
- •Self-report of difficulty staying asleep "Moderate," "Severe," or "Very Severe"
- •Self report of waking up in the middle of the night/early morning one or more times per week
Exclusion Criteria
- •Unable to read or understand English
- •Body Mass Index (weight/height ratio) \>33
- •Self-report of being diagnosed with apnea
- •Current or past history of a neurological disorder or psychiatric illness
- •Self-report that it takes less than 30 minutes to fall asleep on average
- •Severe Clinical insomnia symptoms (ISI \> 21)
- •Good sleepers (PSQI \< 6)
- •High risk for severe Generalized Anxiety Disorder (GAD-7 \> 15)
- •Moderate to high risk for alcohol abuse disorder (AUDIT \>6)
- •individuals that are actively being treated for anxiety, insomnia, ADHD or other psychological disorders with medications
Outcomes
Primary Outcomes
Change in Sleep Onset Latency (SOL) from Sham Block Compared to Stimulation Block
Time Frame: At the completion of the study (14 days), including at least 4 days in each block.
SOL will be determined using objective EEG-based metrics (e.x. time to first observed sleep spindle) derived from recommendations set forth by the American Academy of Sleep Medicine (AASM). SOL will be assessed for each study day during the sham block in which the device is worn but inactive and compared to SOL for the days in the stimulation block, in which the device is actively delivering auditory stimulation. Subjects will randomly be assigned in regards to the order of sham and stimulation blocks.
Secondary Outcomes
- Sleep Onset Latency After Wake After Sleep Onset Events (WASO) During Sham Stimulation Sessions Compared to Active Stimulation Sessions(At the completion of the study (7-14 days).)
- Change in Subjective Sleep Onset Latency (SOL) from Sham Block Compared to Stimulation Block(At the completion of the study (14 days).)
- Change in Subjective Daytime Sleepiness (Karolinska Sleepiness Scale) from Sham Block Compared to Stimulation Block(At the completion of the study (14 days).)
- Change in Sleep Efficiency During Sham Block Compared to Stimulation Block(At the completion of the study (14 days), including at least 4 days in each block.)